Schering AG Makes Oncology A Primary Focus; Dermatology No Longer “Core”
Executive Summary
Schering AG is establishing a new global oncology business unit that will be headquartered in the U.S
You may also be interested in...
Schering AG dermatology business “Intendis”
Schering AG names separate dermatology business group Intendis. Company will formally begin operations Jan. 1. U.S. headquarters in Montville, N.J. will house about 70 out of approximately 600 global Intendis employees. Managing Director Wolfgang Kehr will lead global headquarters in Berlin. U.S. management will include North & Latin America Marketing & Sales head Bernhard Schefter. Schering announced in June it was spinning off "non-core" businesses to focus on oncology (1"The Pink Sheet" June 21, 2004, p. 38)....
Schering AG dermatology business “Intendis”
Schering AG names separate dermatology business group Intendis. Company will formally begin operations Jan. 1. U.S. headquarters in Montville, N.J. will house about 70 out of approximately 600 global Intendis employees. Managing Director Wolfgang Kehr will lead global headquarters in Berlin. U.S. management will include North & Latin America Marketing & Sales head Bernhard Schefter. Schering announced in June it was spinning off "non-core" businesses to focus on oncology (1"The Pink Sheet" June 21, 2004, p. 38)....
Berlex To Submit Angeliq NDA Response In March, Add Cardioprotective Data
Schering AG's Berlex subsidiary expects to complete its response to FDA on its NDA for the hormone replacement therapy Angeliq in March